T-type Ca2+ channel enhancer SAK3 administration improves the BPSD-like behaviors in AppNL-G-F/NL-G-F knock-in mice
Publication date: Available online 26 February 2021Source: Journal of Pharmacological SciencesAuthor(s): Tomohide Degawa, Ichiro Kawahata, Hisanao Izumi, Yasuharu Shinoda, Kohji Fukunaga
Source: Journal of Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology